Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo
- PMID: 20739515
- PMCID: PMC2953143
- DOI: 10.1128/JVI.01703-09
Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo
Erratum in
- J Virol. 2011 Jan;85(1):650
Abstract
The type I alpha/beta interferons (IFN-α/β) are known to play an important role in host defense against influenza A virus infection, but we have now discovered that the recently identified type III IFNs (IFN-λ) constitute the major response to intranasal infection with this virus. Type III IFNs were present at much higher levels than type I IFNs in the lungs of infected mice, and the enhanced susceptibility of STAT2-/- animals demonstrated that only signaling through the IFN-α/β or IFN-λ pathways was sufficient to mediate protection. This finding offers a possible explanation for the similar levels of antiviral protection found in wild-type (WT) mice and in animals lacking a functional type I IFN receptor (IFNAR-/-) but also argues that our current understanding of type III IFN induction is incomplete. While murine IFN-λ production is thought to depend on signaling through the type I IFN receptor, we demonstrate that intranasal influenza A virus infection leads to the robust type III IFN induction in the lungs of both WT and IFNAR-/- mice. This is consistent with previous studies showing that IFNAR-mediated protection is redundant for mucosal influenza virus infection and with data showing that the type III IFN receptor is expressed primarily by epithelial cells. However, the overlapping effects of these two cytokine families are limited by their differential receptor expression, with a requirement for IFN-α/β signaling in combating systemic disease.
Figures
![FIG. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2953143/bin/zjv9990938610001.gif)
![FIG. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2953143/bin/zjv9990938610002.gif)
![FIG. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2953143/bin/zjv9990938610003.gif)
![FIG. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2953143/bin/zjv9990938610004.gif)
![FIG. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2953143/bin/zjv9990938610005.gif)
Similar articles
-
Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines.J Virol. 2019 Nov 13;93(23):e01262-19. doi: 10.1128/JVI.01262-19. Print 2019 Dec 1. J Virol. 2019. PMID: 31511392 Free PMC article.
-
Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response.J Virol. 2019 Oct 29;93(22):e01073-19. doi: 10.1128/JVI.01073-19. Print 2019 Nov 15. J Virol. 2019. PMID: 31462571 Free PMC article.
-
Interferon-λ in the context of viral infections: production, response and therapeutic implications.J Innate Immun. 2014;6(5):563-74. doi: 10.1159/000360084. Epub 2014 Apr 17. J Innate Immun. 2014. PMID: 24751921 Free PMC article. Review.
-
Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection.PLoS Pathog. 2014 Jan;10(1):e1003845. doi: 10.1371/journal.ppat.1003845. Epub 2014 Jan 2. PLoS Pathog. 2014. PMID: 24391501 Free PMC article.
-
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Immunol Rev. 2008. PMID: 19161414 Review.
Cited by
-
STAT1 regulates neutrophil gelatinase B-associated lipocalin induction in influenza-induced myocarditis.Sci Rep. 2024 May 15;14(1):11124. doi: 10.1038/s41598-024-61953-z. Sci Rep. 2024. PMID: 38750107 Free PMC article.
-
Identification of common genes of rhinovirus single/double‑stranded RNA‑induced asthma deterioration by bioinformatics analysis.Exp Ther Med. 2024 Mar 20;27(5):210. doi: 10.3892/etm.2024.12498. eCollection 2024 May. Exp Ther Med. 2024. PMID: 38590566 Free PMC article.
-
IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.mBio. 2024 May 8;15(5):e0055024. doi: 10.1128/mbio.00550-24. Epub 2024 Mar 26. mBio. 2024. PMID: 38530032 Free PMC article.
-
Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract.Pathogens. 2024 Jan 26;13(2):113. doi: 10.3390/pathogens13020113. Pathogens. 2024. PMID: 38392851 Free PMC article. Review.
-
Influenza A infections: predictors of disease severity.Braz J Microbiol. 2024 Mar;55(1):75-86. doi: 10.1007/s42770-023-01186-w. Epub 2023 Dec 5. Braz J Microbiol. 2024. PMID: 38049661
References
-
- Ank, N., M. B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, U. B. Jensen, F. Dagnaes-Hansen, A. R. Thomsen, Z. Chen, H. Haugen, K. Klucher, and S. R. Paludan. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J. Immunol. 180:2474-2485. - PubMed
-
- Berghall, H., J. Siren, D. Sarkar, I. Julkunen, P. B. Fisher, R. Vainionpaa, and S. Matikainen. 2006. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microbes Infect. 8:2138-2144. - PubMed
-
- Bourmakina, S. V., and A. Garcia-Sastre. 2003. Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84:517-527. - PubMed
-
- Bustamante, J., S. Boisson-Dupuis, E. Jouanguy, C. Picard, A. Puel, L. Abel, and J. L. Casanova. 2008. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr. Opin. Immunol. 20:39-48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous